SECsense Logo

Carisma Therapeutics Inc.: January 2025 8-K Current Report Unveiled

$CARM
Form 8-K
Filed on: 2025-01-13
Source
Carisma Therapeutics Inc.: January 2025 8-K Current Report Unveiled

Here's the extracted key information from the provided financial report section:

  1. Entity Information:
  • Name: Carisma Therapeutics Inc.
  • CIK Number: 0001485003
  • Address: 3675 Market Street Suite 401, Philadelphia, PA 19104
  • Phone Number: 267-491-6422
  1. SEC Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 13, 2025
  • SEC Central Index Key (CIK): 0001485003
  • File Number: 001-36296
  • EIN: 26-2025616
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Ticker Symbol: CARM
  • Exchange: NASDAQ
  1. Financial Reporting Context:
  • Reporting Period: January 13, 2025
  • Currency: USD (U.S. Dollar)
  • Measurement Units:
    • USD
    • Shares
    • USD per Share
  1. Schema Reference:
  • Schema File: carm-20250113.xsd

Insights:

  • Carisma Therapeutics Inc. is actively reporting financial information as of January 13, 2025, which may indicate that the company is engaged in significant activities or events that warrant current reporting.
  • The use of a common stock ticker (CARM) on NASDAQ suggests public trading and a need for transparency and compliance with SEC regulations.
  • The specific filing (8-K) is used for reporting unscheduled material events or corporate changes, indicating that the company may have relevant news for investors.

This information can be crucial for investors, analysts, or stakeholders interested in the company's current status and financial activities.